These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 38962322

  • 1. Molecular characterization of carbapenem and ceftazidime-avibactam-resistant Enterobacterales and horizontal spread of bla NDM-5 gene at a Lebanese medical center.
    Sobh G, Araj GF, Finianos M, Sourenian T, Hrabak J, Pappagianitsis CC, Chaar ME, Bitar I.
    Front Cell Infect Microbiol; 2024; 14():1407246. PubMed ID: 38962322
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient.
    Zhou J, Yan G, Tang C, Liu J, Fu P, Ding L, Yang W, Guo Y, Wang C, Lu G, Hu F.
    Int J Antimicrob Agents; 2024 Jun; 63(6):107163. PubMed ID: 38570018
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ceftazidime-Avibactam Resistance Associated with Increased blaKPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae.
    Coppi M, Di Pilato V, Monaco F, Giani T, Conaldi PG, Rossolini GM.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31964792
    [Abstract] [Full Text] [Related]

  • 9. Spreading Patterns of NDM-Producing Enterobacteriaceae in Clinical and Environmental Settings in Yangon, Myanmar.
    Sugawara Y, Akeda Y, Hagiya H, Sakamoto N, Takeuchi D, Shanmugakani RK, Motooka D, Nishi I, Zin KN, Aye MM, Myint T, Tomono K, Hamada S.
    Antimicrob Agents Chemother; 2019 Mar 24; 63(3):. PubMed ID: 30530602
    [Abstract] [Full Text] [Related]

  • 10. Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis.
    Wang M, Hao M, Cui X, Liu M, Zhang C, Wang S.
    Int J Antimicrob Agents; 2024 Aug 24; 64(2):107237. PubMed ID: 38851461
    [Abstract] [Full Text] [Related]

  • 11. Ceftazidime-Avibactam resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae: A phenotypic and genotypic analysis.
    Krithika VM, Ganesan V, Rajendran T.
    Indian J Med Microbiol; 2024 Aug 24; 49():100603. PubMed ID: 38705276
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Emergence of a novel sequence type carbapenem-resistant hypervirulent Klebsiella pneumoniae ST6417 harboring blaNDM-5 on the lncX3 plasmid.
    Liu J, Yuan S, Xuan L, Sun Y, Zhang X, Qiao L, Du X.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0098424. PubMed ID: 39162259
    [Abstract] [Full Text] [Related]

  • 14. Molecular Mechanisms Driving the In Vivo Development of KPC-71-Mediated Resistance to Ceftazidime-Avibactam during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections.
    Li X, Ke H, Wu W, Tu Y, Zhou H, Yu Y.
    mSphere; 2021 Dec 22; 6(6):e0085921. PubMed ID: 34935448
    [Abstract] [Full Text] [Related]

  • 15. A large-scale surveillance revealed that KPC variants mediated ceftazidime-avibactam resistance in clinically isolated Klebsiella pneumoniae.
    Qiao S, Xin S, Zhu Y, Zhao F, Wu H, Zhang J, Yao B, Yu Y, Fu Y, Jiang Y, Xie X, Zhang J.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0025824. PubMed ID: 38958437
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals.
    Castanheira M, Doyle TB, Deshpande LM, Mendes RE, Sader HS.
    Int J Antimicrob Agents; 2021 Nov 06; 58(5):106439. PubMed ID: 34547421
    [Abstract] [Full Text] [Related]

  • 19. Emergence of KPC-2 and NDM-5-coproducing hypervirulent carbapenem-resistant Klebsiella pneumoniae with high-risk sequence types ST11 and ST15.
    Zhou Y, Wu X, Wu C, Zhou P, Yang Y, Wang B, Xu Y, Zhao H, Guo Y, Yu J, Yu F.
    mSphere; 2024 Jan 30; 9(1):e0061223. PubMed ID: 38193656
    [Abstract] [Full Text] [Related]

  • 20. Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae.
    Venditti C, Butera O, Meledandri M, Balice MP, Cocciolillo GC, Fontana C, D'Arezzo S, De Giuli C, Antonini M, Capone A, Messina F, Nisii C, Di Caro A.
    Clin Microbiol Infect; 2021 Jul 30; 27(7):1040.e1-1040.e6. PubMed ID: 33775814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.